Epilepsy

The supplied grounding supports multiple etiologic contributors rather than a single cause. Epilepsy is often associated with prior lesions or injury in the nervous system, and inflammatory processes in injured neural tissue are described as important in its development. Glutamate-mediated neuronal hyperexcitation is also described as a causative factor in seizure generation.

The core mechanism is excessive neuronal discharge leading to recurrent seizures. Grounding highlights glutamate-mediated hyperexcitation, especially through AMPA and NMDA receptors, as well as inflammatory signaling that can increase neuronal excitability, impair cell survival, and increase blood-brain barrier permeability. The literature also links epilepsy-related biology to signal transduction, neuronal plasticity, action potentials, oxidative stress, and pathways involving protein serine-threonine kinases including TOR serine-threonine kinases.

Prior lesions in the nervous system are described as commonly associated with epilepsy. The literature also supports inflammatory states in the brain or systemic disorders as contributors to epilepsy development, and sleep deprivation is presented as a factor that negatively affects brain function and is relevant to neurological disorders. No additional risk factors are supported by the supplied grounding.

The supplied grounding supports antiseizure drug therapy and non-drug neuromodulation approaches. Cannabidiol is specifically co-studied, and the literature also discusses glutamate receptor antagonism as a therapeutic strategy, with perampanel noted as an approved AMPA-receptor antagonist. Vagus nerve stimulation is described as a nondrug therapy, and surgery is included among the covered management modalities, but no further treatment specifics are supported here.